Literature DB >> 20386369

State of the science: hypoxic ischemic encephalopathy and hypothermic intervention for neonates.

Laura D Selway1.   

Abstract

Perinatal asphyxia and resulting hypoxic ischemic encephalopathy (HIE) occur in 1 to 3 per 1000 births in the United States. Induced hypothermia as an intervention for asphyxiated infants offers promising results in reducing neurodevelopmental disabilities in surviving infants. Induced hypothermia and selective head cooling are effective interventions for asphyxiated infants that minimize continued neuronal damage and decrease neurodevelopmental disability at 18 months of age. Identification of affected infants immediately after delivery and transfer to a facility that provides this therapy is necessary to maximize the potential of this intervention. Standardization of hypothermia protocols within neonatal intensive care units is essential for providing hypothermia as a treatment of HIE in infants. This article explores the pathophysiology of HIE, identifying infants at risk for HIE as a result of perinatal asphyxia, the use of hypothermic intervention for compromised infants, and barriers to the implementation of treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20386369     DOI: 10.1097/ANC.0b013e3181d54b30

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  11 in total

1.  Disruption of the serotonergic system after neonatal hypoxia-ischemia in a rodent model.

Authors:  Kathryn M Buller; Julie A Wixey; Hanna E Reinebrant
Journal:  Neurol Res Int       Date:  2012-02-08

2.  Interactions between oxygen homeostasis, food availability, and hydrogen sulfide signaling.

Authors:  Nicole N Iranon; Dana L Miller
Journal:  Front Genet       Date:  2012-11-27       Impact factor: 4.599

3.  Increased concentrations of both NMDA receptor co-agonists D-serine and glycine in global ischemia: a potential novel treatment target for perinatal asphyxia.

Authors:  Sabine A Fuchs; Cacha M P C D Peeters-Scholte; Martina M J de Barse; Martin W Roeleveld; Leo W J Klomp; Ruud Berger; Tom J de Koning
Journal:  Amino Acids       Date:  2011-09-23       Impact factor: 3.520

4.  NQDI-1, an inhibitor of ASK1 attenuates acute perinatal hypoxic-ischemic cerebral injury by modulating cell death.

Authors:  Hu Hao; Sitao Li; Hui Tang; Bingqing Liu; Yao Cai; Congcong Shi; Xin Xiao
Journal:  Mol Med Rep       Date:  2016-04-13       Impact factor: 2.952

5.  NG25, an inhibitor of transforming growth factor‑β‑activated kinase 1, ameliorates neuronal apoptosis in neonatal hypoxic‑ischemic rats.

Authors:  Hua Wang; Zhong Chen; Yu Li; Qiaoyun Ji
Journal:  Mol Med Rep       Date:  2017-11-10       Impact factor: 2.952

6.  A new Hypoxic Ischemic Encephalopathy model in neonatal rats.

Authors:  Hao Lyu; Dong Ming Sun; Chi Ping Ng; Jun Fan Chen; Yu Zhong He; Sin Yu Lam; Zhi Yuan Zheng; Hadi Askarifirouzjaei; Chi Chiu Wang; Wise Young; Wai Sang Poon
Journal:  Heliyon       Date:  2021-12-20

Review 7.  Combination of stem cell therapy and acupuncture to treat ischemic stroke: a prospective review.

Authors:  Huidong Jia; Jia He; Xuemin Shi; Hua Ye; Lan Zhao; Chia-Chen Hsu; Xiaofeng Zhao; Yuzheng Du; Lin Han; Zhanfeng Cui
Journal:  Stem Cell Res Ther       Date:  2022-03-03       Impact factor: 6.832

8.  Knockdown of IL-1β improves hypoxia-ischemia brain associated with IL-6 up-regulation in cell and animal models.

Authors:  Sujuan Liu; Shengyun Zhu; Yu Zou; Tinghua Wang; Xuemei Fu
Journal:  Mol Neurobiol       Date:  2014-06-26       Impact factor: 5.590

Review 9.  Stem cell therapy for neonatal hypoxic-ischemic encephalopathy.

Authors:  Gabriel S Gonzales-Portillo; Stephanny Reyes; Daniela Aguirre; Mibel M Pabon; Cesar V Borlongan
Journal:  Front Neurol       Date:  2014-08-12       Impact factor: 4.003

10.  Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy.

Authors:  Usama M Alkholy; Nermin Abdalmonem; Ahmed Zaki; Yasser F Ali; Soma Abdalla Mohamed; Nasser I Abdelsalam; Mustafa Ismail Abu Hashim; Mohamed Abou Sekkien; Yasser Makram Elsherbiny
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.